(ISSN: 1741-0541)
Personalized Medicine translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved – academic, clinical and industrial researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. The journal addresses scientific, commercial and policy issues in personalized medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.
Coverage includes:
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.
The journal welcomes unsolicited article proposals.
http://www.futuremedicine.com/feedback/show
http://www.futuremedicine.com/page/subscribe.jsp
http://www.futuremedicine.com/page/reprints.jsp
http://www.futuremedicine.com/page/journal/pme/editors.jsp
http://www.futuremedicine.com/page/indexing